Step into the future of healthcare with our exclusive roundtable discussion, featuring insights from top industry and policy experts, including senior representation from the Belgian payer RIZIV-INAMI.
This comprehensive whitepaper explores the pivotal role of data, innovation, and policy in transforming the healthcare landscape in Belgium. Delve into the pressing challenges and exciting opportunities that are shaping the path forward, from integrating cutting-edge technologies to fostering a patient-centric approach. Learn about the delicate balance between incentivizing innovation and ensuring affordability, and discover the potential of the "one health" concept to create value for both people and the planet.
Mickael Daubie
RIZIV-INAMI
Director General Health Care Service
Stefaan Fiers
Takeda
Head of Corporate Communication, Public Affairs and Patient Advocacy
Eric Lechien
UCB
Policy, Payers & RWE Operations & Capabilities Head
Eline Picavet
Novartis
Pricing and Reimbursement Head
Dr. Patricia van Dijck
Pharma.be
Political and Medical Director
Marjan Willaert
Pharma.be
Policy Advisor Market Access
Michele Paque
External Senior Advisor, Life Sciences and Healthcare, PwC Belgium
Tel: +32 477 60 50 51